This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Dayforce Set to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
DAY's second-quarter 2025 results are likely to benefit from an expanding clientele and a strong portfolio.
Leidos Holdings to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
LDOS is set to report Q2 results, with all four segments projected to post year-over-year revenue growth.
Will Healthy Top-Line Growth Benefit Motorola's Q2 Earnings?
by Zacks Equity Research
MSI's Q2 results may reflect solid top-line growth, fueled by rising demand for mission-critical tech and new product rollouts.
Can Higher Revenues Benefit Akamai This Earnings Season?
by Zacks Equity Research
AKAM's Q2 revenue is likely to have risen on strong security and compute demand, but EPS may have dipped despite robust product launches.
Broadridge Set to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
BR aims for a modest fiscal Q4 EPS gain, but a projected 5.6% revenue dip may test momentum heading into fiscal 2026.
DXC Technology Company. (DXC) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
DXC Technology (DXC) delivered earnings and revenue surprises of +6.25% and +2.92%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Genpact (G) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Genpact (G) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Peloton Interactive, Genpact, Samsara Inc., Kodiak Gas Services Inc. and Omnicom Group.
G or NOW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
G vs. NOW: Which Stock Is the Better Value Option?
Why Genpact (G) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Will Modest Consulting Revenue Growth Aid IBM's Q2 Earnings?
by Zacks Equity Research
IBM's Q2 Consulting revenue may see modest gains, driven by digital deals with Deutsche Bank and Finanz Informatik.
Why Genpact (G) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Will Higher Software Revenues Buoy IBM's Earnings in Q2?
by Zacks Equity Research
IBM's Q2 results may get a lift from surging Software revenues, driven by watsonx.ai, acquisitions and new AI labs.
Will Genpact (G) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Genpact (G) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Unisys Declines 12% in a Month: Time to Buy, Sell or Hold the Stock?
by Harendra Ray
UIS stock slips 12% in a month, but strong business wins and AI innovation hint at a longer-term recovery.
Here's Why Genpact (G) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Retain Genpact Stock in Your Portfolio Now
by Zacks Equity Research
G earns top sustainability honors, and boosts AI innovation with the new AP Suite and XponentL buyout while raising dividends and buybacks.
Unisys Stock is at a 4.92X P/E: Should You Buy, Sell or Retain?
by Harendra Ray
UIS trades at just 4.92X forward P/E, with major wins in device services and AI fueling its turnaround potential.
Genpact (G) Up 0.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Genpact (G) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for OUSM
Genpact's Earnings and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Genpact's first-quarter 2025 earnings increase 15.1% year over year.
Genpact (G) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 5% and 0.50%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Is ProShares S&P Technology Dividend Aristocrats ETF (TDV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for TDV
Is First Trust Industrials/Producer Durables AlphaDEX ETF (FXR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXR
Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for OUSM